Pituitary clinical trials

Explore recruiting pituitary clinical trials.

Recruiting pituitary studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pituitary trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CoCo-PCOS - Comprehensive Health Effects of Combined Contraceptives: a 6-month randomized, controlled, open-label trial of E4+DRSP, EE20µg+DRSP, and DRSP-only in women with PCOS

Finland

Therapeutic use (Phase IV) EU CTIS Study details

CoCo3 - Comprehensive Health Effects of Combined Contraceptives: a 12-month randomized, controlled, open-label trial of E4+DRSP, EE20μg+DRSP and DRSP-only

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Dopamine agonist treatment of non-functioning pituitary adenomas (NFPAs) – a randomized controlled trial

Norway

Therapeutic use (Phase IV) EU CTIS Study details

SPI-62 as a Treatment for Adrenocorticotropic Hormone- dependent Cushing’s Syndrome

Bulgaria, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

18F-fluoro-ethyl-tyrosine (18FET) PET for difficult clinical situations in functional pituitary adenoma. A prospective, single arm, single center study. (FET-PIT)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Use of [18F]FET PET-MRI to improve detection of pituitary adenomas in Cushing’s disease

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pituitary trials by city

Pituitary in Toronto Pituitary in Vancouver Pituitary in Montreal Pituitary in Calgary Pituitary in Edmonton Pituitary in Ottawa Pituitary in Winnipeg Pituitary in Quebec City Pituitary in Hamilton Pituitary in Kitchener Pituitary in London Pituitary in Halifax Pituitary in New York Pituitary in Los Angeles Pituitary in Chicago Pituitary in Houston

Pituitary clinical trials

Recruiting pituitary studies right now

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

DDAVP for Pituitary Adenoma

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery

VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Growth Hormone Replacement Therapy for Retried Professional Football Players

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH

A Study of Pasireotide in People With Prolactinoma

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

Study of MAR002 in Healthy Men

Also recruiting in Europe

CoCo-PCOS - Comprehensive Health Effects of Combined Contraceptives: a 6-month randomized, controlled, open-label trial of E4+DRSP, EE20µg+DRSP, and DRSP-only in women with PCOS

CoCo3 - Comprehensive Health Effects of Combined Contraceptives: a 12-month randomized, controlled, open-label trial of E4+DRSP, EE20μg+DRSP and DRSP-only

Dopamine agonist treatment of non-functioning pituitary adenomas (NFPAs) – a randomized controlled trial

SPI-62 as a Treatment for Adrenocorticotropic Hormone- dependent Cushing’s Syndrome

18F-fluoro-ethyl-tyrosine (18FET) PET for difficult clinical situations in functional pituitary adenoma. A prospective, single arm, single center study. (FET-PIT)

Use of [18F]FET PET-MRI to improve detection of pituitary adenomas in Cushing’s disease

Pituitary trials by city

Other conditions